State Of Alaska, Department Of Revenue Biogen Inc. Transaction History

State Of Alaska, Department Of Revenue

$8.95 Billion
Q4 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Biogen Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 19,179 shares of BIIB stock, worth $2.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

19,179

Previous 24,870 22.88%

Holding current value

$2.8 Million

Previous $4.82 Million 39.17%

% of portfolio

0.03%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$146.47 - $191.55 $833,560 - $1.09 Million	-5,691 Reduced 22.88%	19,179 $2.93 Million
Q3 2024 Oct 24, 2024	SELL	$189.07 - $236.8 $926,443 - $1.16 Million	-4,900 Reduced 16.46%	24,870 $4.82 Million
Q2 2024 Aug 05, 2024	SELL	$190.52 - $236.72 $737,312 - $916,106	-3,870 Reduced 11.5%	29,770 $6.9 Million
Q1 2024 Apr 19, 2024	SELL	$212.02 - $267.71 $1.04 Million - $1.31 Million	-4,910 Reduced 12.74%	33,640 $7.25 Million
Q4 2023 Jan 19, 2024	SELL	$222.59 - $267.94 $1.92 Million - $2.31 Million	-8,625 Reduced 18.28%	38,550 $9.98 Million
Q3 2023 Oct 16, 2023	SELL	$253.3 - $285.89 $143,114 - $161,527	-565 Reduced 1.18%	47,175 $12.1 Million
Q2 2023 Jul 24, 2023	SELL	$275.25 - $318.06 $254,331 - $293,887	-924 Reduced 1.9%	47,740 $13.6 Million
Q1 2023 Apr 17, 2023	BUY	$256.56 - $292.34 $62,344 - $71,038	243 Added 0.5%	48,664 $13.5 Million
Q4 2022 Jan 11, 2023	BUY	$252.44 - $306.72 $212,554 - $258,258	842 Added 1.77%	48,421 $13.4 Million
Q3 2022 Oct 20, 2022	SELL	$194.69 - $268.46 $424,618 - $585,511	-2,181 Reduced 4.38%	47,579 $12.7 Million
Q2 2022 Jul 08, 2022	SELL	$187.54 - $223.02 $794,231 - $944,489	-4,235 Reduced 7.84%	49,760 $10.1 Million
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $744,076 - $937,497	-3,840 Reduced 6.64%	53,995 $11.4 Million
Q4 2021 Jan 12, 2022	SELL	$223.92 - $287.77 $1.81 Million - $2.33 Million	-8,085 Reduced 12.26%	57,835 $13.9 Million
Q3 2021 Oct 07, 2021	SELL	$282.99 - $369.05 $1.02 Million - $1.33 Million	-3,614 Reduced 5.2%	65,920 $18.7 Million
Q2 2021 Jul 12, 2021	BUY	$259.0 - $414.71 $2.48 Million - $3.97 Million	9,568 Added 15.96%	69,534 $24.1 Million
Q1 2021 Apr 09, 2021	SELL	$242.95 - $284.63 $1.14 Million - $1.34 Million	-4,698 Reduced 7.27%	59,966 $16.8 Million
Q4 2020 Jan 08, 2021	SELL	$236.26 - $355.63 $6.21 Million - $9.35 Million	-26,282 Reduced 28.9%	64,664 $15.8 Million
Q3 2020 Oct 05, 2020	BUY	$264.77 - $305.71 $8.45 Million - $9.76 Million	31,930 Added 54.1%	90,946 $25.8 Million
Q2 2020 Jul 06, 2020	BUY	$258.66 - $342.55 $6.9 Million - $9.14 Million	26,687 Added 82.55%	59,016 $15.8 Million
Q1 2020 Apr 06, 2020	BUY	$268.85 - $341.04 $442,795 - $561,692	1,647 Added 5.37%	32,329 $10.2 Million
Q4 2019 Jan 07, 2020	SELL	$220.06 - $304.07 $677,784 - $936,535	-3,080 Reduced 9.12%	30,682 $9.1 Million
Q3 2019 Oct 02, 2019	BUY	$217.44 - $243.88 $1.01 Million - $1.13 Million	4,633 Added 15.91%	33,762 $7.86 Million
Q2 2019 Jul 23, 2019	SELL	$219.29 - $241.72 $191,220 - $210,779	-872 Reduced 2.91%	29,129 $6.81 Million
Q1 2019 Apr 09, 2019	SELL	$216.71 - $338.96 $256,801 - $401,667	-1,185 Reduced 3.8%	30,001 $7.09 Million
Q4 2018 Jan 10, 2019	BUY	$278.5 - $352.75 $53,472 - $67,728	192 Added 0.62%	31,186 $9.38 Million
Q3 2018 Oct 09, 2018	SELL	$293.51 - $383.83 $429,698 - $561,927	-1,464 Reduced 4.51%	30,994 $10.9 Million
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $1.57 Million - $1.87 Million	6,100 Added 23.14%	32,458 $9.42 Million
Q1 2018 Apr 19, 2018	BUY	$260.13 - $367.91 $1.07 Million - $1.51 Million	4,110 Added 18.47%	26,358 $7.22 Million
Q4 2017 Jan 19, 2018	BUY	$307.64 - $344.58 $6.28 Million - $7.03 Million	20,408 Added 1109.13%	22,248 $7.09 Million
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $517,315 - $606,629	1,840	1,840 $576,000

Others Institutions Holding BIIB

# of Institutions

999

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Biogen Inc. Transaction History